Browsing Tag
PD-L1
6 posts
Insilico Medicine’s AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy
In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade, has made remarkable advances. But…
Blood-based DNA test spares bladder cancer patients from unnecessary treatments
Testing for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse…
Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC
Lung cancer is the leading cause of cancer-related death worldwide. Improved understanding of driver mutations of non-small cell…
Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status
New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug, pembrolizumab, to chemotherapy…
Gut bacteria strains could be the key to predicting cancer treatment success
In a recent study published in Nature Medicine, researchers investigated the composition of the gut microbiota as a…
Combination therapy offers breakthrough in NSCLC treatment
A specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung cancer (NSCLC)…